The University of Maryland is recognized as one of the preeminent public research universities in the nation.

As a top research school, the University of Maryland School of Pharmacy applies an integrative approach to drug discovery and development, innovative patient care, and drug outcomes and their economic impact.

Researchers in the Department of Pharmaceutical Sciences (PSC) are identifying and developing new drugs to treat drug abuse, cancer, metabolic diseases, and infection.

The Department of Pharmaceutical Health Services Research (PHSR) provides valuable information on the economic costs and public policy issues that arise once drugs and therapies have been made available to the public.

Faculty in the Department of Pharmacy Practice and Science (PPS) address health disparities, medication use, and best practices to prevent and treat a variety of diseases, with clinical science research activities focused on gaining a better understanding of drug efficacy and delivery.

The School of Pharmacy received more than $32.1 million in grants and contracts during the 2018 fiscal year.